UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 9 | September 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 7
July-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2407549


Registration ID:
545427

Page Number

f348-f356

Share This Article


Jetir RMS

Title

Novel HPTLC Method Development and Validation for Estimation of Abemaciclib in Tablet Dosage Form

Abstract

A novel, selective, precise, and high performance thin layer chromatographic technique has been developed and validated for estimating Abemaciclib in tablet dosage form. TLC aluminium plates precoated with silica gel 60 F-254 were used as the stationary phase employed TLC Aluminium plates precoated with silica gel 60 F- 254 as the stationary phase. Linear ascending development with Toluene: acetone: methanol: ammonia in the ratio 8:2:2:0.1 (v/v) as the mobile phase. It was concluded at room temperature (25± 20C) phase was performed at room temperature (25 ± 2°C) in a twin trough glass chamber saturated with the mobile phase. Abemaciclib has compact bands (RF 0.42 ± 0.02). Scanning was done in absorbance mode at 298 nm. Linear regression analysis of calibration plots revealed a strong linear association between peak area and peak height (R2=0.9995 and 0.997) in the concentration range of 50-400 ng/band. The method was tested for specificity, precision, accuracy, robustness, detection and quantification limits. The detection and quantification limits were 9.75 and 29.70 ng/band, respectively. The approach achieved recovery rate of 100.28%. This approach can be used as a quality control method to check the purity of Abemaciclib in its tablet dosage form.

Key Words

Abemaciclib, HPTLC, Method development, Validation.

Cite This Article

"Novel HPTLC Method Development and Validation for Estimation of Abemaciclib in Tablet Dosage Form", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 7, page no.f348-f356, July-2024, Available :http://www.jetir.org/papers/JETIR2407549.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Novel HPTLC Method Development and Validation for Estimation of Abemaciclib in Tablet Dosage Form", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 7, page no. ppf348-f356, July-2024, Available at : http://www.jetir.org/papers/JETIR2407549.pdf

Publication Details

Published Paper ID: JETIR2407549
Registration ID: 545427
Published In: Volume 11 | Issue 7 | Year July-2024
DOI (Digital Object Identifier):
Page No: f348-f356
Country: Thane, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000250

Print This Page

Current Call For Paper

Jetir RMS